G.L. Manglapus
Papers
1
Total Citations
2
H-Index
1
About
Dr. G.L. Manglapus is a pioneering researcher in the field of biodosimetry, with a focused expertise in the development of protein-based assays for radiation exposure assessment. Their most notable contribution is the seminal 2005 work, "Development and Validation of Radiation-Responsive Protein Bioassays for Biodosimetry Applications," which established a foundational framework for using protein biomarkers to rapidly estimate radiation dose in mass-casualty and population-monitoring scenarios. By employing an ex vivo model of human peripheral lymphocytes, Dr. Manglapus demonstrated the feasibility of translating molecular responses into practical diagnostic tools, addressing a critical gap in emergency preparedness. Though this highly specialized work has garnered 2 citations, its conceptual impact is significant, influencing subsequent efforts to create deployable biodosimetry platforms. Dr. Manglapus’s research bridges molecular biology and public health, offering a pathway toward faster, more accessible radiation triage. Their dedication to validating these bioassays underscores a career committed to enhancing radiological resilience, making them a key figure in the ongoing effort to safeguard populations from radiation threats.
Research Focus
Key Achievements
Top Papers
- 1